Welldoc for Diabetes

1. New York City Health and Hospitals (NYC H+H) with 273 total participants on BlueStar demonstrated reduction in A1c with an average six-month reduction in A1c (1.1 vs. 0.2; -0.9, p<0.01). There were high levels of engagement with more than half of the participants used the app once a week; recording blood glucose and medications were the most frequently used features (82% and 62% respectively). Of BlueStar participants, 40% were Spanish-speaking and received the Spanish-version of BlueStar. All English- and Spanish-speaking participants found BlueStar easy to use and understand.
2. A top 3 nationally-recognized payor, Healthagen, with Welldoc and LifeScan conducted a study of 291 total participants. Clinically significant reductions in A1c & blood glucose were demonstrated including an average 0.54 reduction in A1c and 1.83 average A1c reduction for those with A1c > 8. There were also reductions in ER visits. There was a 30% decrease in diabetes-related visits and all-cause visits decreased by 55%. A reduction in costs of 55% from baseline to follow-up. Also, strong engagement of ~30 digital engagements per week suggests the tool is an effective mechanism to improve patient self-management of diabetes and increase in self-care behaviors.

The Welldoc solution offers a better way for individuals and health ecosystems to manage chronic conditions. Our solution features validated clinical and financial outcomes, a scalable solution that extends the reach of traditional care and data insights to support clinical decisions and treatment plans across care teams.  

Our approach is to partner with health ecosystems to optimize chronic care. We do this by providing the technology framework for chronic care programs and seamlessly integrating into the daily lives of individuals living with chronic conditions and the existing care models supporting them.

The solution is the combination of three elements:

1) An app that is available to patients on their mobile devices, desktop computer or tablet;

2) A flexible model for integration within a health ecosystem so that health care providers and care teams can receive the right data at the right time to better support their patients care and treatment goals;

3) A population management tool that allows Care Managers to monitor and manage your population.

We partner with health ecosystems to seamlessly integrate into existing care models and optimize chronic care.

• Offers a single, flexible technology platform, originally established to address the complexity of diabetes and now extends to comprehensive chronic care across prediabetes, diabetes, hypertension, heart failure, and behavioral health
• Focus is on partnering with health ecosystems to extend, rather than replace, existing care models. We offer a range of flexible integration options to best suit a customer’s ecosystem.
• Built on a foundation of clinical rigor, evidence and experience– 9 FDA-clearances (type1 and type 2 diabetes), 3 RCTs, 60+ peer-reviewed pubs  
• Powered by advanced AI technology, based on 23 patents to provide meaningful and personalized real-time insights and coaching
• Key strategic partnerships with life science, device and delivery leaders in chronic care to deliver holistic solutions, addressing the emergence of new data-driven solutions entering the market and the growing complexity of managing chronic conditions and comorbidities